Cargando…

Combining DNA Damage Induction with BCL-2 Inhibition to Enhance Merkel Cell Carcinoma Cytotoxicity

Merkel cell carcinoma (MCC) is a highly lethal skin cancer. MCC tumors rapidly develop resistance to the chemotherapies tested to date. While PD-1/PD-L1 immune checkpoint blockade has demonstrated success in MCC treatment, a significant portion of MCC patients are nonresponsive. Therefore, the press...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wei, Krump, Nathan A., Herlyn, Meenhard, You, Jianxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168258/ https://www.ncbi.nlm.nih.gov/pubmed/32093022 http://dx.doi.org/10.3390/biology9020035

Ejemplares similares

From Merkel Cell Polyomavirus Infection to Merkel Cell Carcinoma Oncogenesis
por: Krump, Nathan A., et al.
Publicado: (2021)

Merkel cell polyomavirus and associated Merkel cell carcinoma
por: Yang, June F., et al.
Publicado: (2021)

A short‐term in vivo model for Merkel Cell Carcinoma
por: Bhat, Vishwanath Kumble, et al.
Publicado: (2018)

Inhibiting insulin and mTOR signaling by afatinib and crizotinib combination fosters broad cytotoxic effects in cutaneous malignant melanoma
por: Das, Ishani, et al.
Publicado: (2020)

Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma?
por: Rabinowits, Guilherme
Publicado: (2017)

Merkel Cell Carcinoma Dependence on Bcl-2 Family Members for Survival
por: Verhaegen, Monique E., et al.
Publicado: (2014)

Merkel Cell Polyomavirus DNA in Persons without Merkel Cell Carcinoma
por: Wieland, Ulrike, et al.
Publicado: (2009)

Gene expression profiling of melanoma cells – searching the haystack
por: Brafford, Patricia, et al.
Publicado: (2005)

Narrowing the knowledge gaps for melanoma
por: Slipicevic, Ana, et al.
Publicado: (2012)

Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma
por: Bogenrieder, Thomas, et al.
Publicado: (2002)

Strategic Combination of DNA-Damaging Agent and PARP Inhibitor Results in Enhanced Cytotoxicity
por: Horton, Julie K., et al.
Publicado: (2013)

Re-Induction of Avelumab for Patients with Metastatic Merkel Cell Carcinoma
por: Hiroyuki, Goto, et al.
Publicado: (2023)

Detection of Merkel Cell Polyomavirus (MCPyV) DNA and Transcripts in Merkel Cell Carcinoma (MCC)
por: Passerini, Sara, et al.
Publicado: (2023)

Merkel Cell Polyomavirus and Merkel Cell Carcinoma
por: Pietropaolo, Valeria, et al.
Publicado: (2020)

Bromodomain Protein Brd4 Plays a Key Role in Merkel Cell Polyomavirus DNA Replication
por: Wang, Xin, et al.
Publicado: (2012)

Combined squamous cell carcinoma and Merkel cell carcinoma of the vulva: Role of human papillomavirus and Merkel cell polyomavirus
por: Chen, Chien-Heng, et al.
Publicado: (2015)

TRIM15 and CYLD regulate ERK activation via lysine 63-linked polyubiquitination
por: Zhu, Guixin, et al.
Publicado: (2021)

Treatment of in-transit Merkel cell carcinoma by isolated limb infusion with cytotoxic drugs
por: Hindmarch, Jake J, et al.
Publicado: (2022)

Dual inhibition of anti-apoptotic proteins BCL-XL and MCL-1 enhances cytotoxicity of Nasopharyngeal carcinoma cells
por: Abdul Rahman, Siti Fairus, et al.
Publicado: (2022)

Phosphorylation of Large T Antigen Regulates Merkel Cell Polyomavirus Replication
por: Diaz, Jason, et al.
Publicado: (2014)

Navitoclax combined with Alpelisib effectively inhibits Merkel cell carcinoma cell growth in vitro
por: Chteinberg, Emil, et al.
Publicado: (2020)

Merkel Cell Polyomavirus and Merkel Cell Carcinoma, France
por: Foulongne, Vincent, et al.
Publicado: (2008)

Merkel cell polyomavirus and cutaneous Merkel cell carcinoma
por: Minutilli, Ettore, et al.
Publicado: (2016)

Co-inhibition of BCL-XL and MCL-1 with selective BCL-2 family inhibitors enhances cytotoxicity of cervical cancer cell lines
por: Abdul Rahman, Siti Fairus, et al.
Publicado: (2020)

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression
por: Li, Ling, et al.
Publicado: (2011)

From cancer stem cells to tumor maintenance in melanoma
por: Fukunaga-Kalabis, Mizuho, et al.
Publicado: (2011)

Pre-clinical modeling of cutaneous melanoma
por: Rebecca, Vito W., et al.
Publicado: (2020)

Challenges in the humanized mouse model for cancer: A commentary
por: Ramirez-Salazar, Eric, et al.
Publicado: (2021)

Characterization of molecular mechanisms driving Merkel cell polyomavirus oncogene transcription and tumorigenic potential
por: Yang, June F., et al.
Publicado: (2023)

Merkel Cell Polyomavirus Strains in Patients with Merkel Cell Carcinoma
por: Touzé, Antoine, et al.
Publicado: (2009)

Merkel cell polyomavirus in Merkel cell carcinoma of Italian patients
por: Paolini, Francesca, et al.
Publicado: (2011)

Prokineticins and Merkel cell polyomavirus infection in Merkel cell carcinoma
por: Lauttia, S, et al.
Publicado: (2014)

Epidemiology of Merkel Cell Polyomavirus Infection and Merkel Cell Carcinoma
por: Silling, Steffi, et al.
Publicado: (2022)

Merkel cell carcinoma
por: Koljonen, Virve
Publicado: (2006)

Merkel Cell Carcinoma
por: Dellambra, Elena, et al.
Publicado: (2021)

Merkel cell carcinoma
por: Mistry, K., et al.
Publicado: (2021)

Evolving Applications of Circulating Tumor DNA in Merkel Cell Carcinoma
por: Prakash, Varsha, et al.
Publicado: (2023)

Matricellular Proteins Produced by Melanocytes and Melanomas: In Search for Functions
por: Fukunaga-Kalabis, Mizuho, et al.
Publicado: (2008)

Autophagy Paradox: Strategizing Treatment Modality in Melanoma
por: Pangilinan, Christian, et al.
Publicado: (2023)

Association of Merkel Cell Polyomavirus–Specific Antibodies With Merkel Cell Carcinoma
por: Carter, Joseph J., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3jo54b5oiikiroa0bdigo2k0a2